EGFR and chronic obstructive pulmonary disease: Based on the FDA Adverse Events Reporting System (FAERS), a public database that contains nearly 17 million (adverse event) AE reports, EGFR TKIs have been associated with HF and cardiac arrhythmias such as atrial fibrillation and QT prolongation (117).